{"pmid":32315756,"title":"Challenges of managing the asymptomatic carriers of SARS-CoV-2.","text":["Challenges of managing the asymptomatic carriers of SARS-CoV-2.","After an outbreak in Wuhan, China, a growing number of countries are now suffering from an epidemic by SARS-CoV-2, which causes COVID-19. Undoubtedly, reports of the skyrocketing global spread of COVID-19 has shocked people globally, from Japan to the United States.Presently, the World Health Organization indicates that fatality due to COVID-19 is about 2%, inferring that many positive subjects may potentially overcome the illness with mild influenza-like symptoms and no need for hospitalization at intensive-care units. Because COVID-19 is completely new to the human immune system, many throughout the world are likely vulnerable to becoming sick after their initial exposure to SARSCoV-2. Besides hospitalized cases, many individuals are likely asymptomatic but potentially carry the virus. While our knowledge about carriers and their virus shedding is deficient, some studies modelling the viral transmission have considered the potential contribution of the asymptomatic carriers. Protocols for managing asymptomatic cases, for example for controlling them to restrict their contact with healthy people at public places or private residences, have not been established.In-house quarantine may as well be applicable to asymptomatic cases if they could be identified and diagnosed. Presumably now, the asymptomatic subjects potentially contribute to the transmission of COVID-19 without their knowledge, intention or being diagnosed as carriers. Thus, managing the asymptomatic cases, who can carry and likely transmit the virus, is a major healthcare challenge while a pandemic is looming.","Travel Med Infect Dis","Rahimi, Farid","Bezmin Abadi, Amin Talebi","32315756"],"abstract":["After an outbreak in Wuhan, China, a growing number of countries are now suffering from an epidemic by SARS-CoV-2, which causes COVID-19. Undoubtedly, reports of the skyrocketing global spread of COVID-19 has shocked people globally, from Japan to the United States.Presently, the World Health Organization indicates that fatality due to COVID-19 is about 2%, inferring that many positive subjects may potentially overcome the illness with mild influenza-like symptoms and no need for hospitalization at intensive-care units. Because COVID-19 is completely new to the human immune system, many throughout the world are likely vulnerable to becoming sick after their initial exposure to SARSCoV-2. Besides hospitalized cases, many individuals are likely asymptomatic but potentially carry the virus. While our knowledge about carriers and their virus shedding is deficient, some studies modelling the viral transmission have considered the potential contribution of the asymptomatic carriers. Protocols for managing asymptomatic cases, for example for controlling them to restrict their contact with healthy people at public places or private residences, have not been established.In-house quarantine may as well be applicable to asymptomatic cases if they could be identified and diagnosed. Presumably now, the asymptomatic subjects potentially contribute to the transmission of COVID-19 without their knowledge, intention or being diagnosed as carriers. Thus, managing the asymptomatic cases, who can carry and likely transmit the virus, is a major healthcare challenge while a pandemic is looming."],"journal":"Travel Med Infect Dis","authors":["Rahimi, Farid","Bezmin Abadi, Amin Talebi"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32315756","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.tmaid.2020.101677","source":"PubMed","topics":["Prevention","Transmission"],"weight":1,"locations":["Wuhan","China","Japan","United States"],"countries":["China","United States","Japan"],"countries_codes":["CHN|China","USA|United States","JPN|Japan"],"_version_":1664714520026677248,"score":8.518259,"similar":[{"pmid":32321904,"title":"Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","text":["Asymptomatic carriers of COVID-19 as a concern for disease prevention and control: more testing, more follow-up.","Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection.","Biosci Trends","Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong","32321904"],"abstract":["Following a containment phase of two months, China has transitioned to the mitigation phase. However, China still faces the risk of COVID-19 spreading due to not only to sporadic new cases and imported cases but also asymptomatic carriers. According to daily reports from the National Health Commission of the People's Republic of China from March 31, 2020 to April 7, 2020, the number of new asymptomatic cases reported daily greatly exceeded that of new imported cases. As of 24:00 on April 7, there were a total of 1,095 asymptomatic cases with COVID-19 under medical observation on the Chinese mainland, including 358 imported cases. A growing number of studies have indicated that asymptomatic carriers are infectious to an extent and can potentially transmit COVID-19. At present, China's measures for managing asymptomatic carriers are 14 days of centralized quarantine and observation; in principle, people with two consecutive negative nucleic acid tests (at an interval of at least 24 hours) can be released from quarantine. However, asymptomatic carriers will not be included in confirmed cases unless they develop clinical manifestations while in quarantine. As \"silent spreaders\", asymptomatic carriers warrant attention as part of disease prevention and control. The testing and follow-up of asymptomatic carriers should be expanded to include people in close contact with patients with confirmed COVID-19 and asymptomatic cases, clusters of outbreaks, and key areas and populations with a high risk of infection."],"journal":"Biosci Trends","authors":["Zhang, Jiao","Wu, Shoucai","Xu, Lingzhong"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32321904","week":"202017|Apr 20 - Apr 26","doi":"10.5582/bst.2020.03069","keywords":["china","asymptomatic infections","coronavirus disease 2019 (covid-19)"],"source":"PubMed","topics":["Diagnosis","Prevention","Transmission"],"weight":1,"locations":["China","China","Chinese","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664895932744859648,"score":259.69092},{"pmid":32141279,"title":"[Advances on presymptomatic or asymptomatic carrier transmission of COVID-19].","text":["[Advances on presymptomatic or asymptomatic carrier transmission of COVID-19].","COVID-19 is rapidly spreading. Patients in incubation period and healthy carriers are possible sources for transmission. However, such sources of infection cannot be effectively identified due to the symptoms absent. The research evidence is very lacking so far, although there are a few studies suggesting that presymptomatic or asymptomatic carrier may cause COVID-19 transmission. Nearly half of the literature is in the state of preprint without peer review. The question of \"the degree to which presymptomatic or asymptomatic infections can transmit\" is not fully understood. There is an urgent need to screen infected carriers in larger close contacts or in the general population, and assess their risk for transmission.","Zhonghua Liu Xing Bing Xue Za Zhi","Gao, W J","Li, L M","32141279"],"abstract":["COVID-19 is rapidly spreading. Patients in incubation period and healthy carriers are possible sources for transmission. However, such sources of infection cannot be effectively identified due to the symptoms absent. The research evidence is very lacking so far, although there are a few studies suggesting that presymptomatic or asymptomatic carrier may cause COVID-19 transmission. Nearly half of the literature is in the state of preprint without peer review. The question of \"the degree to which presymptomatic or asymptomatic infections can transmit\" is not fully understood. There is an urgent need to screen infected carriers in larger close contacts or in the general population, and assess their risk for transmission."],"journal":"Zhonghua Liu Xing Bing Xue Za Zhi","authors":["Gao, W J","Li, L M"],"date":"2020-03-07T11:00:00Z","year":2020,"_id":"32141279","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.cn112338-20200228-00207","keywords":["2019-ncov","asymptomatic transmission","covid-19","presymptomatic transmission","source of infection"],"source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1664640874934435840,"score":209.9219},{"pmid":32322400,"pmcid":"PMC7171182","title":"Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view.","text":["Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view.","Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, the number of globally confirmed cases according to World Health Organization statistics reached 292 124 in 189 countries by 22 March 2020. The number of deaths reached 12 784, with estimated case-fatality rates ranging from 0.5% to 5.7%. Children population seems to be the least affected by the disease, while the highest rate of death is among the elderly and people with comorbidities. Most infected individuals are asymptomatic or only exhibit mild symptoms. After the incubation period, the most common symptoms are fever, cough and fatigue. Asymptomatic carrier state is of paramount importance because of carriers' ability to spread the infection and to shed the virus into the air and surroundings. Although much is still unknown about SARS-CoV-2, the scientific research is moving at an unprecedented pace towards understanding the nature, effective control, prevention and treatment of SARS-CoV-2. Various reports have suggested an in vivo evolution of the virus, which may explain the rapid spread and changing epidemiology of SARS-CoV-2, but further evidence is needed. Unfortunately, no effective treatment or therapeutic drug is available for the disease; only supportive treatment and classical intervention measures are available for confronting the SARS-CoV-2 pandemic.","New Microbes New Infect","Abduljalil, J M","Abduljalil, B M","32322400"],"abstract":["Since the emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, the number of globally confirmed cases according to World Health Organization statistics reached 292 124 in 189 countries by 22 March 2020. The number of deaths reached 12 784, with estimated case-fatality rates ranging from 0.5% to 5.7%. Children population seems to be the least affected by the disease, while the highest rate of death is among the elderly and people with comorbidities. Most infected individuals are asymptomatic or only exhibit mild symptoms. After the incubation period, the most common symptoms are fever, cough and fatigue. Asymptomatic carrier state is of paramount importance because of carriers' ability to spread the infection and to shed the virus into the air and surroundings. Although much is still unknown about SARS-CoV-2, the scientific research is moving at an unprecedented pace towards understanding the nature, effective control, prevention and treatment of SARS-CoV-2. Various reports have suggested an in vivo evolution of the virus, which may explain the rapid spread and changing epidemiology of SARS-CoV-2, but further evidence is needed. Unfortunately, no effective treatment or therapeutic drug is available for the disease; only supportive treatment and classical intervention measures are available for confronting the SARS-CoV-2 pandemic."],"journal":"New Microbes New Infect","authors":["Abduljalil, J M","Abduljalil, B M"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32322400","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.nmni.2020.100672","keywords":["2109-ncov","asymptomatic","covid-19","coronavirus","epidemic","europe","pneumonia","quarantine","transmission"],"source":"PubMed","topics":["Diagnosis","Treatment","Mechanism"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664895932723888129,"score":181.87335},{"pmid":32146694,"title":"Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","text":["Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China.","Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged.","Sci China Life Sci","Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing","32146694"],"abstract":["Previous studies have showed clinical characteristics of patients with the 2019 novel coronavirus disease (COVID-19) and the evidence of person-to-person transmission. Limited data are available for asymptomatic infections. This study aims to present the clinical characteristics of 24 cases with asymptomatic infection screened from close contacts and to show the transmission potential of asymptomatic COVID-19 virus carriers. Epidemiological investigations were conducted among all close contacts of COVID-19 patients (or suspected patients) in Nanjing, Jiangsu Province, China, from Jan 28 to Feb 9, 2020, both in clinic and in community. Asymptomatic carriers were laboratory-confirmed positive for the COVID-19 virus by testing the nucleic acid of the pharyngeal swab samples. Their clinical records, laboratory assessments, and chest CT scans were reviewed. As a result, none of the 24 asymptomatic cases presented any obvious symptoms while nucleic acid screening. Five cases (20.8%) developed symptoms (fever, cough, fatigue, etc.) during hospitalization. Twelve (50.0%) cases showed typical CT images of ground-glass chest and 5 (20.8%) presented stripe shadowing in the lungs. The remaining 7 (29.2%) cases showed normal CT image and had no symptoms during hospitalization. These 7 cases were younger (median age: 14.0 years; P=0.012) than the rest. None of the 24 cases developed severe COVID-19 pneumonia or died. The median communicable period, defined as the interval from the first day of positive nucleic acid tests to the first day of continuous negative tests, was 9.5 days (up to 21 days among the 24 asymptomatic cases). Through epidemiological investigation, we observed a typical asymptomatic transmission to the cohabiting family members, which even caused severe COVID-19 pneumonia. Overall, the asymptomatic carriers identified from close contacts were prone to be mildly ill during hospitalization. However, the communicable period could be up to three weeks and the communicated patients could develop severe illness. These results highlighted the importance of close contact tracing and longitudinally surveillance via virus nucleic acid tests. Further isolation recommendation and continuous nucleic acid tests may also be recommended to the patients discharged."],"journal":"Sci China Life Sci","authors":["Hu, Zhiliang","Song, Ci","Xu, Chuanjun","Jin, Guangfu","Chen, Yaling","Xu, Xin","Ma, Hongxia","Chen, Wei","Lin, Yuan","Zheng, Yishan","Wang, Jianming","Hu, Zhibin","Yi, Yongxiang","Shen, Hongbing"],"date":"2020-03-09T11:00:00Z","year":2020,"_id":"32146694","week":"202011|Mar 09 - Mar 15","doi":"10.1007/s11427-020-1661-4","keywords":["covid-19","china","asymptomatic infections","close contact"],"source":"PubMed","topics":["Mechanism","Diagnosis","Transmission"],"weight":1,"locations":["Nanjing","Jiangsu","China","Nanjing","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874887249920,"score":179.59396},{"pmid":32179910,"title":"Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China.","text":["Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China.","An epidemic caused by SARS-Coronavirus-2 infection has spread unexpectedly in Wuhan, Hubei Province, China since December 2019. It is rarely reported about asymptomatic cases screened from close contacts. We study epidemiological and clinical outcome of 55 asymptomatic carriers who were laboratory-confirmed positive for the SARS-Coronavirus-2 by testing the nucleic acid of the pharyngeal swab samples. The evidence showed that asymptomatic carriers occurred more often in middle aged people who had close contact with infected family members. The majority of the cases developed to be mild and ordinary COVID-19 during hospital.","J Infect Dis","Wang, Yanrong","Liu, Yingxia","Liu, Lei","Wang, Xianfeng","Luo, Nijuan","Ling, Li","32179910"],"abstract":["An epidemic caused by SARS-Coronavirus-2 infection has spread unexpectedly in Wuhan, Hubei Province, China since December 2019. It is rarely reported about asymptomatic cases screened from close contacts. We study epidemiological and clinical outcome of 55 asymptomatic carriers who were laboratory-confirmed positive for the SARS-Coronavirus-2 by testing the nucleic acid of the pharyngeal swab samples. The evidence showed that asymptomatic carriers occurred more often in middle aged people who had close contact with infected family members. The majority of the cases developed to be mild and ordinary COVID-19 during hospital."],"journal":"J Infect Dis","authors":["Wang, Yanrong","Liu, Yingxia","Liu, Lei","Wang, Xianfeng","Luo, Nijuan","Ling, Li"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32179910","week":"202012|Mar 16 - Mar 22","doi":"10.1093/infdis/jiaa119","keywords":["sars-coronavirus-2","asymptomatic infection","outcome"],"source":"PubMed","weight":0,"locations":["Wuhan","Hubei","China","Shenzhen","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640874602037248,"score":179.10463}]}